First Trust Direct Indexing’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,712
Closed -$1.43M 604
2024
Q3
$1.43M Sell
2,712
-315
-10% -$154K 0.08% 260
2024
Q2
$1.32M Buy
3,027
+168
+6% +$76.7K 0.08% 250
2024
Q1
$1.37M Buy
2,859
+102
+4% +$47K 0.1% 218
2023
Q4
$1.29M Buy
2,757
+459
+20% +$215K 0.12% 198
2023
Q3
$1.01M Sell
2,298
-435
-16% -$191K 0.12% 194
2023
Q2
$1.25M Sell
2,733
-295
-10% -$134K 0.14% 163
2023
Q1
$1.4M Buy
3,028
+197
+7% +$91.4K 0.17% 145
2022
Q4
$1.54M Sell
2,831
-165
-6% -$86.1K 0.2% 121
2022
Q3
$1.41M Buy
2,996
+157
+6% +$74.8K 0.21% 120
2022
Q2
$1.36M Buy
2,839
+351
+14% +$161K 0.19% 133
2022
Q1
$1.11M Buy
2,488
+353
+17% +$146K 0.14% 189
2021
Q4
$826K Sell
2,135
-256
-11% -$95.3K 0.11% 234
2021
Q3
$861K Buy
2,391
+237
+11% +$85.7K 0.12% 209
2021
Q2
$783K Buy
2,154
+671
+45% +$242K 0.12% 225
2021
Q1
$480K Buy
1,483
+122
+9% +$36.8K 0.13% 219
2020
Q4
$415K Buy
+1,361
New +$416K 0.11% 227

Other funds holding NOC

First Trust Direct Indexing's NOC Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Northrop Grumman (NOC) in Q4 2024, closing a stake of 2,712 shares — an estimated $1.43M sold.

First Trust Direct Indexing first reported a position in NOC in Q4 2020 and held it in 16 quarters. The position peaked at $1.54M in Q4 2022. 1,640 funds tracked by Wall St. Rank hold NOC as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Northrop Grumman position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 2,712 Northrop Grumman shares in Q4 2024, an estimated $1.43M.
  • First Trust Direct Indexing first reported a position in Northrop Grumman in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Northrop Grumman position peaked at $1.54M in Q4 2022.
  • 1,640 funds tracked by Wall St. Rank held Northrop Grumman as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.